Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | GPX4 | P36969 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 5/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12573122 | 1.00 | MAPT (0.50) | MAPTMCHR1KCNH2CNR2DNM1 | |
| SCHEMBL26256139 | 1.00 | MAPT (0.50) | MAPTMCHR1KCNH2CNR2DNM1 | |
| SCHEMBL28526661 | 1.00 | MAPT (0.50) | MAPTMCHR1KCNH2CNR2DNM1 | |
| SCHEMBL26025426 | 1.00 | MAPT (0.50) | MAPTMCHR1KCNH2CNR2DNM1 | |
| Hydrochloric Acid SCHEMBL3665640 | 0.98 | MAPT (0.49) | MAPTMCHR1KCNH2CNR2DNM1 | |
| Hydrochloric Acid SCHEMBL5713117 | 0.98 | MAPT (0.49) | MAPTMCHR1KCNH2CNR2DNM1 | |
| Hydrochloric Acid SCHEMBL5713125 | 0.98 | MAPT (0.49) | MAPTMCHR1KCNH2CNR2DNM1 | |
| SCHEMBL13261438 | 0.98 | MAPT (0.51) | MAPTMCHR1KCNH2CNR2DNM1 | |
| SCHEMBL8484830 | 0.92 | MAPT (0.58) | MAPTMCHR1KCNH2CNR2ALDH1A1 | |
| SCHEMBL16520720 | 0.92 | ALDH1A1 (0.50) | MAPTMCHR1KCNH2CNR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130118570-A1 | DYE FOR PHOTOELECTRIC CONVERSION, SEMICONDUCTOR ELECTRODE, PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND NOVEL PYRROLINE-BASED COMPOUND | NEC CORPORATION (JP) | 2013-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130118570-A1 | DYE FOR PHOTOELECTRIC CONVERSION, SEMICONDUCTOR ELECTRODE, PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND NOVEL PYRROLINE-BASED COMPOUND | SCO2, PYCR1, CRY1 | MAPT 4341/4885MCHR1 189/4885KCNH2 64/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.